Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
9-AC in Advanced Renal Cell Carcinoma
NCT00003551Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 1998
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of 9-aminocamptothecin in renal cell carcinoma (RCC), sponsored by Emory University. Started Aug 1998; status: completed.
02
Drugs
9-aminocamptothecin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003551.